This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...